Regenerative Treatments
for Ophthalmic Diseases
Neuroptika’s mission is to improve patients’ lives by developing novel regenerative therapies for ophthalmic diseases
PIPELINE
NRO-1
Neurotrophic Keratitis
NRO-CMK
Nerve degeneration prevention gene therapy
NRO-VTN
Novel geographic atrophy target
PHASE 1
PRECLINICAL
PHASE 2
UNDER CONSTRUCTION
Detailed program descriptions to follow